Related Experiment Video
Updated: Jul 24, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Potential role of postmarketing research
1Medical Department, Ciba-Geigy Ltd., Basle, Switzerland.
Drugs Under Experimental and Clinical Research
|January 1, 1987
Summary
Conducting postmarketing studies to assess both benefits and risks is challenging due to differing trial designs. Improving data quality and standardization is crucial for efficient and accurate pharmaceutical research.
Area of Science:
- Pharmacovigilance and Postmarketing Surveillance
- Clinical Trial Methodology
- Pharmaceutical Research and Development
Background:
- Simultaneously evaluating beneficial and adverse effects in postmarketing studies presents significant methodological challenges.
- Postmarketing research differs substantially from pre-approval clinical trials (Phases I-III) in terms of study conditions and design.
- Pharmaceutical companies face challenges in postmarketing research due to data independence, patient group heterogeneity, and consideration of concomitant therapies.
Purpose of the Study:
- To highlight the methodological difficulties in conducting integrated benefit-risk assessments during postmarketing surveillance.
- To emphasize the need for improved data quality, integration, and interpretation in postmarketing research.
- To advocate for the adoption of standardized terminologies and categorization criteria to enhance the value of postmarketing data.
Main Methods:
- The abstract discusses the inherent differences between pre-approval clinical trials and postmarketing studies.
- It highlights the complexities arising from real-world data, including diverse patient populations and co-therapies.
- The text implicitly calls for methodological advancements in handling heterogeneous and large-scale postmarketing data.
Main Results:
- Postmarketing studies yield valuable real-world data but face challenges in data integration and interpretation.
- Lack of standardized terminologies and data quality control leads to information loss and misinterpretation.
- Current approaches risk compromising the cost-efficiency and reliability of postmarketing surveillance.
Conclusions:
- Methodological improvements are essential for effective postmarketing benefit-risk assessment.
- Standardization of data collection, terminology, and quality assurance is critical for maximizing the utility of postmarketing data.
- Addressing these challenges will significantly enhance the cost-efficiency and scientific rigor of postmarketing research.
More Related Videos
06:39Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
Published on: August 28, 2017
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...